(Q34499440)

2 August 2017

1 reference

title

Opioid formulations: tailoring to the needs in chronic pain (English)

1 reference

2 August 2017

0 references

0 references

Reder RF

1

1 reference

2 August 2017

publication date

1 January 2001

1 reference

2 August 2017

published in

European Journal of Pain

1 reference

2 August 2017

volume

5 Suppl A

1 reference

2 August 2017

page(s)

109-111

1 reference

Relative potency of controlled-release oxycodone and controlled-release morphine in a postoperative pain model

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0291

Controlled-release oxycodone and morphine in cancer related pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0291

Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0291

Can a controlled-release oral dose form of oxycodone be used as readily as an immediate-release form for the purpose of titrating to stable pain control?

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0291

Double-blind, randomized comparison of the analgesic and pharmacokinetic profiles of controlled- and immediate-release oral oxycodone in cancer pain patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0291

Analgesic efficacy of controlled-release oxycodone in postoperative pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0291

Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0291

Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0291

Long-term administration of controlled-release oxycodone tablets for the treatment of cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0291

Efficacy and safety of controlled-release versus immediate-release oxycodone: randomized, double-blind evaluation in patients with chronic back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0291

Comparison of controlled-release and immediate-release oxycodone tablets in patients with cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0291

Controlled-release oxycodone compared with controlled-release morphine in the treatment of cancer pain: a randomized, double-blind, parallel-group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0291

The use of controlled-release oxycodone for the treatment of chronic cancer pain: a randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0291

21 January 2018

Identifiers

DOI

10.1053/EUJP.2001.0291

1 reference

2 August 2017

1 reference